Skip to main content
Top
Gepubliceerd in: Quality of Life Research 4/2014

01-05-2014

Validation and comparison of 15-D and EQ-5D-5L instruments in a Spanish Parkinson’s disease population sample

Auteurs: Miguel Ángel García-Gordillo, Borja del Pozo-Cruz, José Carmelo Adsuar, Fernando Ignacio Sánchez-Martínez, José María Abellán-Perpiñán

Gepubliceerd in: Quality of Life Research | Uitgave 4/2014

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

To contribute to the ongoing discussion on the choice of a preference-based health-related quality of life (HRQoL) instrument to be used in cost-effectiveness analysis by studying and comparing the validity, sensitivity and relative efficiency of 15-D and EuroQol 5D 5L (EQ-5D-5L) in a Spanish Parkinson’s disease (PD) population sample.

Methods

One hundred and thirty-three volunteers were asked to complete an interview using 15-D and EQ-5D-5L. Spearman’s rank correlation coefficient (r) was used to test the convergent validity of these instruments with specific PD measures. Sensitivity and efficiency were compared using receiver operating characteristic (ROC) curves and relative efficiency statistic, respectively.

Results

A strong correlation (r > 0.65; p < 0.001) was found between both 15-D and EQ-5D-5L utilities with the summary score of the PDQ-8, and a strong correlation (r > 0.50; p < 0.001) was found between 15-D and EQ-5D-5L utilities with the EQ-VAS. The areas under the ROC of both instruments all exceeded 0.5 (p < 0.001). The 15-D instrument was 4.1–29.8 % less efficient at detecting differences between patients with optimal HRQoL, while this instrument was 11 % more efficient at detecting differences between patients at mild and moderate to strong severity of the PD symptoms.

Conclusions

15-D and EQ-5D-5L are showed to be valid and sensitivity generic HRQoL measures in Spanish PD patients with both instruments showing similar HRQoL dimension coverage and ceiling/floor effects. The 15-D has better efficiency and greater sensitivity to detect clinical changes in PD severity of the symptoms meanwhile the EQ-5D-5L is better to detect clinical HRQoL changes. Additionally, the EQ-5D-5L questionnaire requires less time than 15-D to be administered, and it might be more appropriate for studies conducted in Spain, since a country-specific “value set” is available for this instrument and not for the 15-D.
Literatuur
1.
go back to reference Lees, A. J., Hardy, J., & Revesz, T. (2009). Parkinson’s disease. Lancet, 373(9680), 2055–2066.PubMedCrossRef Lees, A. J., Hardy, J., & Revesz, T. (2009). Parkinson’s disease. Lancet, 373(9680), 2055–2066.PubMedCrossRef
2.
go back to reference Yousefi, B., Tadibi, V., Fathollahzadeh Khoei, A., & Montazeri, A. (2009). Exercise therapy, quality of life, and activities of daily living in patients with Parkinson disease: A small scale quasi-randomised trial. Trials, 10(1), 67.PubMedCentralPubMedCrossRef Yousefi, B., Tadibi, V., Fathollahzadeh Khoei, A., & Montazeri, A. (2009). Exercise therapy, quality of life, and activities of daily living in patients with Parkinson disease: A small scale quasi-randomised trial. Trials, 10(1), 67.PubMedCentralPubMedCrossRef
3.
go back to reference Goodwin, V. A., Richards, S. H., Taylor, R. S., Taylor, A. H., & Campbell, J. L. (2008). The effectiveness of exercise interventions for people with Parkinson’s disease: A systematic review and meta-analysis. Movement Disorders, 23(5), 631–640.PubMedCrossRef Goodwin, V. A., Richards, S. H., Taylor, R. S., Taylor, A. H., & Campbell, J. L. (2008). The effectiveness of exercise interventions for people with Parkinson’s disease: A systematic review and meta-analysis. Movement Disorders, 23(5), 631–640.PubMedCrossRef
4.
go back to reference Wilson, I. B., & Cleary, P. D. (1995). Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. Journal of the American Medical Association, 273(1), 59–65.PubMedCrossRef Wilson, I. B., & Cleary, P. D. (1995). Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. Journal of the American Medical Association, 273(1), 59–65.PubMedCrossRef
5.
go back to reference Peto, V., Jenkinson, C., Fitzpatrick, R., & Greenhall, R. (1995). The development and validation of a short measure of functioning and well being for individuals with Parkinson’s disease. Quality of Life Research, 4(3), 241–248.PubMedCrossRef Peto, V., Jenkinson, C., Fitzpatrick, R., & Greenhall, R. (1995). The development and validation of a short measure of functioning and well being for individuals with Parkinson’s disease. Quality of Life Research, 4(3), 241–248.PubMedCrossRef
6.
go back to reference de Boer, A. G., Wijker, W., Speelman, J. D., & de Haes, J. C. (1996). Quality of life in patients with Parkinson’s disease: Development of a questionnaire. Journal of Neurology, Neurosurgery and Psychiatry, 61(1), 70–74.PubMedCentralPubMedCrossRef de Boer, A. G., Wijker, W., Speelman, J. D., & de Haes, J. C. (1996). Quality of life in patients with Parkinson’s disease: Development of a questionnaire. Journal of Neurology, Neurosurgery and Psychiatry, 61(1), 70–74.PubMedCentralPubMedCrossRef
7.
go back to reference Jenkinson, C., & Fitzpatrick, R. (2007). Cross-cultural evaluation of the short form 8-item Parkinson’s disease questionnaire (PDQ-8): Results from America, Canada, Japan, Italy and Spain. Parkinsonism & Related Disorders, 13(1), 22–28.CrossRef Jenkinson, C., & Fitzpatrick, R. (2007). Cross-cultural evaluation of the short form 8-item Parkinson’s disease questionnaire (PDQ-8): Results from America, Canada, Japan, Italy and Spain. Parkinsonism & Related Disorders, 13(1), 22–28.CrossRef
8.
go back to reference Brazier, J., Deverill, M., & Green, C. (1999). A review of the use of health status measures in economic evaluation. Journal of Health Services Research & Policy, 4(3), 174–184. Brazier, J., Deverill, M., & Green, C. (1999). A review of the use of health status measures in economic evaluation. Journal of Health Services Research & Policy, 4(3), 174–184.
9.
go back to reference Drummond, M., Sculpher, M., Torrance, G. W., O’Brien, B., & Stoddart, G. (2005). Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press. Drummond, M., Sculpher, M., Torrance, G. W., O’Brien, B., & Stoddart, G. (2005). Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press.
10.
go back to reference Younossi, Z. M., & Guyatt, G. (1998). Quality-of-life assessments and chronic liver disease. American Journal of Gastroenterology, 93(7), 1037–1041.PubMedCrossRef Younossi, Z. M., & Guyatt, G. (1998). Quality-of-life assessments and chronic liver disease. American Journal of Gastroenterology, 93(7), 1037–1041.PubMedCrossRef
11.
go back to reference Sintonen, H. (2001). The 15D instrument of health-related quality of life: Properties and applications. Annals of Medicine, 33(5), 328–336.PubMedCrossRef Sintonen, H. (2001). The 15D instrument of health-related quality of life: Properties and applications. Annals of Medicine, 33(5), 328–336.PubMedCrossRef
12.
go back to reference Rasanen, P., Roine, E., Sintonen, H., Semberg-Konttinen, V., Ryynanen, O. P., & Roine, R. (2006). Use of quality-adjusted life years for the estimation of effectiveness of health care: A systematic literature review. International Journal of Technology Assessment in Health Care, 22(2), 235–241.PubMedCrossRef Rasanen, P., Roine, E., Sintonen, H., Semberg-Konttinen, V., Ryynanen, O. P., & Roine, R. (2006). Use of quality-adjusted life years for the estimation of effectiveness of health care: A systematic literature review. International Journal of Technology Assessment in Health Care, 22(2), 235–241.PubMedCrossRef
13.
go back to reference Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, D., et al. (2011). Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Quality of Life Research, 20(10), 1727–1736.PubMedCentralPubMedCrossRef Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, D., et al. (2011). Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Quality of Life Research, 20(10), 1727–1736.PubMedCentralPubMedCrossRef
14.
go back to reference Martinez-Martin, P., Jeukens-Visser, M., Lyons, K. E., Rodriguez-Blazquez, C., Selai, C., Siderowf, A., et al. (2011). Health-related quality-of-life scales in Parkinson’s disease: Critique and recommendations. Movement Disorders, 26(13), 2371–2380.PubMedCrossRef Martinez-Martin, P., Jeukens-Visser, M., Lyons, K. E., Rodriguez-Blazquez, C., Selai, C., Siderowf, A., et al. (2011). Health-related quality-of-life scales in Parkinson’s disease: Critique and recommendations. Movement Disorders, 26(13), 2371–2380.PubMedCrossRef
15.
go back to reference Haapaniemi, T. H., Sotaniemi, K. A., Sintonen, H., & Taimela, E. (2004). The generic 15D instrument is valid and feasible for measuring health related quality of life in Parkinson’s disease. Journal of Neurology, Neurosurgery and Psychiatry, 75(7), 976–983.PubMedCentralPubMedCrossRef Haapaniemi, T. H., Sotaniemi, K. A., Sintonen, H., & Taimela, E. (2004). The generic 15D instrument is valid and feasible for measuring health related quality of life in Parkinson’s disease. Journal of Neurology, Neurosurgery and Psychiatry, 75(7), 976–983.PubMedCentralPubMedCrossRef
16.
go back to reference Luo, N., Ng, W. Y., Lau, P. N., Au, W. L., & Tan, L. C. (2010). Responsiveness of the EQ-5D and 8-item Parkinson’s disease questionnaire (PDQ-8) in a 4-year follow-up study. Quality of Life Research, 19(4), 565–569.PubMedCrossRef Luo, N., Ng, W. Y., Lau, P. N., Au, W. L., & Tan, L. C. (2010). Responsiveness of the EQ-5D and 8-item Parkinson’s disease questionnaire (PDQ-8) in a 4-year follow-up study. Quality of Life Research, 19(4), 565–569.PubMedCrossRef
17.
go back to reference Luo, N., Low, S., Lau, P. N., Au, W. L., & Tan, L. C. (2009). Is EQ-5D a valid quality of life instrument in patients with Parkinson’s disease? A study in Singapore. Annals of the Academy of Medicine, Singapore, 38(6), 521–528.PubMed Luo, N., Low, S., Lau, P. N., Au, W. L., & Tan, L. C. (2009). Is EQ-5D a valid quality of life instrument in patients with Parkinson’s disease? A study in Singapore. Annals of the Academy of Medicine, Singapore, 38(6), 521–528.PubMed
18.
go back to reference Goetz, C. G., Poewe, W., Rascol, O., Sampaio, C., Stebbins, G. T., Counsell, C., et al. (2004). Movement disorder society task force report on the Hoehn and Yahr staging scale: Status and recommendations. Movement Disorders, 19(9), 1020–1028.PubMedCrossRef Goetz, C. G., Poewe, W., Rascol, O., Sampaio, C., Stebbins, G. T., Counsell, C., et al. (2004). Movement disorder society task force report on the Hoehn and Yahr staging scale: Status and recommendations. Movement Disorders, 19(9), 1020–1028.PubMedCrossRef
20.
go back to reference Siderowf, A. D., & Werner, R. M. (2001). The EQ-5D–a generic quality of life measure—Is a useful instrument to measure quality of life in patients with Parkinson’s disease. Journal of Neurology, Neurosurgery and Psychiatry, 70(6), 817.PubMedCentralPubMedCrossRef Siderowf, A. D., & Werner, R. M. (2001). The EQ-5D–a generic quality of life measure—Is a useful instrument to measure quality of life in patients with Parkinson’s disease. Journal of Neurology, Neurosurgery and Psychiatry, 70(6), 817.PubMedCentralPubMedCrossRef
21.
go back to reference Martinez-Martin, P., & Deuschl, G. (2007). Effect of medical and surgical interventions on health-related quality of life in Parkinson’s disease. Movement Disorders, 22(6), 757–765.PubMedCrossRef Martinez-Martin, P., & Deuschl, G. (2007). Effect of medical and surgical interventions on health-related quality of life in Parkinson’s disease. Movement Disorders, 22(6), 757–765.PubMedCrossRef
22.
go back to reference Martinez-Martin, P., & Kurtis, M. M. (2009). Systematic review of the effect of dopamine receptor agonists on patient health-related quality of life. Parkinsonism & Related Disorders, 15(Suppl 4), S58–S64.CrossRef Martinez-Martin, P., & Kurtis, M. M. (2009). Systematic review of the effect of dopamine receptor agonists on patient health-related quality of life. Parkinsonism & Related Disorders, 15(Suppl 4), S58–S64.CrossRef
23.
go back to reference Hoehn, M. M., & Yahr, M. D. (2001). Parkinsonism: Onset, progression, and mortality. Neurology, 57(10 Suppl 3), S11–S26.PubMed Hoehn, M. M., & Yahr, M. D. (2001). Parkinsonism: Onset, progression, and mortality. Neurology, 57(10 Suppl 3), S11–S26.PubMed
24.
go back to reference Cohen, J. (1988). Statistical power analysis for the behavioural sciences (2nd ed.). Hillsdale, NJ: Lawrence Erlbaum. Cohen, J. (1988). Statistical power analysis for the behavioural sciences (2nd ed.). Hillsdale, NJ: Lawrence Erlbaum.
25.
go back to reference Kontodimopoulos, N., Pappa, E., Papadopoulos, A. A., Tountas, Y., & Niakas, D. (2009). Comparing SF-6D and EQ-5D utilities across groups differing in health status. Quality of Life Research, 18(1), 87–97.PubMedCrossRef Kontodimopoulos, N., Pappa, E., Papadopoulos, A. A., Tountas, Y., & Niakas, D. (2009). Comparing SF-6D and EQ-5D utilities across groups differing in health status. Quality of Life Research, 18(1), 87–97.PubMedCrossRef
26.
go back to reference Fayers, P. M., & Machin, D. (2007). Quality of life: The assessment, analysis and interpretation of patient-reported outcomes (2nd ed.). Chichester, West Sussex, UK: Wiley.CrossRef Fayers, P. M., & Machin, D. (2007). Quality of life: The assessment, analysis and interpretation of patient-reported outcomes (2nd ed.). Chichester, West Sussex, UK: Wiley.CrossRef
27.
go back to reference Bland, J. M., & Altman, D. G. (1986). Statistical methods for assessing agreement between two methods of clinical measurement. Lancet, 1(8476), 307–310.PubMedCrossRef Bland, J. M., & Altman, D. G. (1986). Statistical methods for assessing agreement between two methods of clinical measurement. Lancet, 1(8476), 307–310.PubMedCrossRef
28.
go back to reference Stucki, G., Liang, M. H., Fossel, A. H., & Katz, J. N. (1995). Relative responsiveness of condition-specific and generic health status measures in degenerative lumbar spinal stenosis. Journal of Clinical Epidemiology, 48(11), 1369–1378.PubMedCrossRef Stucki, G., Liang, M. H., Fossel, A. H., & Katz, J. N. (1995). Relative responsiveness of condition-specific and generic health status measures in degenerative lumbar spinal stenosis. Journal of Clinical Epidemiology, 48(11), 1369–1378.PubMedCrossRef
29.
go back to reference Luo, N., Tan, L. C., Zhao, Y., Lau, P. N., Au, W. L., & Li, S. C. (2009). Determination of the longitudinal validity and minimally important difference of the 8-item Parkinson’s disease questionnaire (PDQ-8). Movement Disorders, 24(2), 183–187.PubMedCrossRef Luo, N., Tan, L. C., Zhao, Y., Lau, P. N., Au, W. L., & Li, S. C. (2009). Determination of the longitudinal validity and minimally important difference of the 8-item Parkinson’s disease questionnaire (PDQ-8). Movement Disorders, 24(2), 183–187.PubMedCrossRef
30.
go back to reference Fitzpatrick, R., Peto, V., Jenkinson, C., Greenhall, R., & Hyman, N. (1997). Health-related quality of life in Parkinson’s disease: A study of outpatient clinic attenders. Movement Disorders, 12(6), 916–922.PubMedCrossRef Fitzpatrick, R., Peto, V., Jenkinson, C., Greenhall, R., & Hyman, N. (1997). Health-related quality of life in Parkinson’s disease: A study of outpatient clinic attenders. Movement Disorders, 12(6), 916–922.PubMedCrossRef
31.
go back to reference Honkalampi, T., & Sintonen, H. (2010). Do the 15D scores and time trade-off (TTO) values of hospital patients’ own health agree? International Journal of Technology Assessment in Health Care, 26(1), 117–123.PubMedCrossRef Honkalampi, T., & Sintonen, H. (2010). Do the 15D scores and time trade-off (TTO) values of hospital patients’ own health agree? International Journal of Technology Assessment in Health Care, 26(1), 117–123.PubMedCrossRef
32.
go back to reference Stavem, K. (1999). Reliability, validity and responsiveness of two multiattribute utility measures in patients with chronic obstructive pulmonary disease. Quality of Life Research, 8(1–2), 45–54.PubMedCrossRef Stavem, K. (1999). Reliability, validity and responsiveness of two multiattribute utility measures in patients with chronic obstructive pulmonary disease. Quality of Life Research, 8(1–2), 45–54.PubMedCrossRef
33.
go back to reference Lubetkin, E. I., Jia, H., Franks, P., & Gold, M. R. (2005). Relationship among sociodemographic factors, clinical conditions, and health-related quality of life: examining the EQ-5D in the U.S. general population. Quality of Life Research, 14(10), 2187–2196.PubMedCrossRef Lubetkin, E. I., Jia, H., Franks, P., & Gold, M. R. (2005). Relationship among sociodemographic factors, clinical conditions, and health-related quality of life: examining the EQ-5D in the U.S. general population. Quality of Life Research, 14(10), 2187–2196.PubMedCrossRef
Metagegevens
Titel
Validation and comparison of 15-D and EQ-5D-5L instruments in a Spanish Parkinson’s disease population sample
Auteurs
Miguel Ángel García-Gordillo
Borja del Pozo-Cruz
José Carmelo Adsuar
Fernando Ignacio Sánchez-Martínez
José María Abellán-Perpiñán
Publicatiedatum
01-05-2014
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 4/2014
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-013-0569-4

Andere artikelen Uitgave 4/2014

Quality of Life Research 4/2014 Naar de uitgave